Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Use of a Sodium-Glucose Cotransporter 2 Inhibitor, Empagliflozin, in a Patient with Rabson-Mendenhall Syndrome.

Hormone research in paediatrics - 1 Jan 2021

Dos Santos Sarah Simaan, Ramaldes Luana Aparecida, Gabbay Monica Andrade Lima, Moises Regina Celia Santiago, Dib Sergio Atala

Abstract excerpt

INTRODUCTION: Among the insulin resistance syndromes that lead to diabetes mellitus in young people, Rabson-Mendenhall syndrome (RMS; OMIM # 262190) is an autosomal recessive inherited disease caused by an insulin receptor mutation (INSR; 147,670). Due to the rarity and complexity of the disease, we have few therapeutic alternatives other than insulin with clinical studies with robust evidence. Some reports...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD
Share to Benzhydryl Compounds

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glucosides

Share to Insulin Resistance

Share to Mutation

Share to Receptor, Insulin

Source

Identifiers

PMID: 34551418
DOI: 10.1159/000519613

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Use of a Sodium-Glucose Cotransporter 2 Inhibitor, Empagliflozin, in a Patient with Rabson-Mendenhall Syndrome.PMID 34551418Read ↗

Use of a sodium--glucose cotransporter 2 inhibitor, empagliflozin, in a patient with Rabson-Mendehall SyndromeSemantic proximity Read ↗

Management challenges of Rabson Mendenhall syndrome in a resource limited country: a case report.Semantic proximity Read ↗

Successful rhIGF1 treatment for over 5 years in a patient with severe insulin resistance due to homozygous insulin receptor mutation.Semantic proximity Read ↗

Genealogical Rabson-Mendenhall syndrome caused by INSR gene mutation.Semantic proximity Read ↗

INSR novel mutations identified in a Chinese family with severe INSR-related insulin resistance syndromes: A case report.Semantic proximity Read ↗

A Novel Mutation in the INSR Gene Causes Severe Insulin Resistance and Rabson-Mendenhall Syndrome in a Paraguayan Patient.Semantic proximity Read ↗

Metreleptin Improves Blood Glucose in Patients With Insulin Receptor MutationsSemantic proximity Read ↗

Mecasermin in Insulin Receptor-Related Severe Insulin Resistance Syndromes: Case Report and Review of the Literature.Semantic proximity Read ↗

A Case Report: Treatment, follow-up, and literature review of type A insulin resistance syndrome caused by a De Novo INSR c.3328G>C mutation.Semantic proximity Read ↗

Rabson-Mendenhall syndrome with recurrent cerebral infarcts caused by a novel INSR mutation.Semantic proximity Read ↗

A Novel Mutation in the INSR Causes Severe Insulin Resistance and Rabson-Mendenhall Syndrome in a Paraguayan PatientSemantic proximity Read ↗

Treatment of a case of severe insulin resistance as a result of a PIK3R1 mutation with a sodium-glucose cotransporter 2 inhibitor.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.